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West Nile (WN) fever is a mosquito-borne flaviviral
infection transmitted in natural cycles between birds and
mosquitoes, particularly Culex species. In humans, WN
infection is usually an asymptomatic or mild febrile illness;
however, encephalitis cases are reported with some fatalities
in older patients. WN virus is also a cause of animal disease,
especially in horses.
WN virus was discovered in 1937 in the blood of a woman
in the West Nile Province of Uganda who had a mild febrile
illness (1). Since then, both sporadic cases and major
outbreaks of WN fever in humans and equines have been
reported in Africa, the Middle East, Europe, and Asia (2), and
many aspects of WN infection have been well documented
elsewhere since the early 1950s (3-7). During the last 5 years,
many reports about WN virus have been published (8-17).
In France, the first reported outbreak occurred during the
summer of 1962 in the Camargue region (Bouches-du-Rhône
Province). At that time, several horses had neurologic
disorders. As many of these horses were living wild, the exact
number of animals with clinical symptoms was not known.
However, among domestic horses for which information was
available, 50 cases with neurologic signs, 25% to 30% of them
fatal, were reported during the summer of 1962, with a peak
between August 15 and September 15. The disease was
mainly characterized by ataxia, weakness, and amaurosis (6).
Several human cases of encephalitis were also reported
during the same period in Camargue and Languedoc (Herault
Province). However, no precise data were available for these
patients except for one who was hospitalized with fever and
meningitis and who had antibodies against group B
arboviruses (18). WN virus infection could not be confirmed
until 1964, when the virus was isolated in September from
Culex modestus mosquitoes and the blood of two
entomologists working in the field (19). Subsequently, 13
human patients, recorded from September 1962 to September
1964, were confirmed by hemagglutination-inhibition and
neutralization tests to have infection compatible with WN
virus (5), including one fatal case (September 1962). In 1963
and 1964, a serosurvey was conducted in 47 horses located in
Camargue, including 10 animals who had neurologic signs in
1962. Neutralizing antibodies against WN virus were
detected in 6 of 37 animals without clinical symptoms and 6 of
10 with previous disease (6). In 1965, WN virus infection was
confirmed in three horses with neurologic signs, including one
fatal case from which virus was isolated from the spinal cord.
The same year, virus also was isolated from Cx. modestus
mosquitoes (20).
After 1965, there was no evidence of WN virus infections
in humans or horses. During a serosurvey (hemagglutination-
inhibition assay) conducted in Camargue from 1975 to 1979,
a low frequency of antibody response against WN virus was
observed in 235 human samples (4.9%) and 99 horse samples
(2%) (21). In contrast, a high frequency was observed against
Tahyna virus (31% in humans and 9% in horses), a
Bunyavirus belonging to the California group that induces
febrile illness with central nervous system signs and has been
reported in many countries in Europe as well as in Africa and
Asia (22).
Materials and Methods
The Outbreak
On September 6, 2000, WN immunoglobulin M (IgM)-
capture enzyme-linked immunosorbent assay (MAC-ELISA)
and indirect IgG ELISA results were positive for two samples
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from horses. These horses were located in the same village in
the south of France (Lansargues, Hérault), approximately 10
km from Montpellier (Figure 1). On August 24 and 28, they
had signs of acute neurologic disorders, characterized by high
fever and paresis of the hindquarters, then paralysis of the
hind legs and inability to get up. The horses were euthanized
on August 30 and September 1, respectively. Retrospectively,
the same veterinary practitioner reported the case of a horse
in the same village, which had clinical symptoms compatible
with WN virus infection on August 3 and died 9 days later.
WN infection was confirmed on September 8 by detection of
WN viral RNA in a brain biopsy of one horse sampled for
rabies diagnosis.
An alert was launched by both the ministry of health and
the ministry of agriculture. Mosquito larvicide, targeted at
Cx. modestus mosquitoes, was applied on September 9 to an
area of about 200 ha near the confirmed cases. Restricted
movement measures imposed by the Commission of the
European Communities, were applied to equines within a 25-
km radius area around a holding on which WN fever was
confirmed in equines during the previous 30 days. These
equidae were held for 21 days in isolation quarantine, after
which MAC-ELISA was performed by a method derived from
Zeller et al. (23). Briefly, IgM antibodies were captured with a
goat anti-horse mu-chain antibody (Sigma Chemical Co., St.
Louis, MO). WN antigen, prepared on Vero E6 cells and
inactivated by beta-propiolactone, was added. Specific
binding was demonstrated by using a WN mouse immune
ascitic fluid and a peroxydase-labeled anti-mouse antibody.
IgG antibodies in sera were detected by a method derived from
Tsai et al. (11). Plates were coated with WN antigen, and IgG
antibodies were revealed by a peroxydase-labeled anti-horse
IgG antibody (Biosis, Compiègne, France). Sera were
considered positive if the optical density was >3 standard
deviations above the mean of negatives.
Results
As of November 30, we had received samples from 129
horses and 2 donkeys clinically suspected of having WN virus
infection by veterinary practitioners (neurologic signs such as
ataxia, paresis, or paralysis, with or without fever >38.5°C). A
confirmed case was defined as illness in an equine with
clinical suspicion of WN virus infection and a positive WN
virus IgM antibody test result; a probable case had a negative
WN virus IgM test result and a positive IgG antibody test
result. A total of 58 equines were defined as having confirmed
cases (57 horses and 1 donkey) and 18 horses as probable
cases. Twenty (34%) of the animals with confirmed cases and
one (6%) of the probable cases died. Eight of the 58 confirmed
cases had a negative IgG antibody test result; 4 of these 8 died.
Of the probable cases, two had samples obtained 15 and 23
days after illness onset; the rest had samples obtained during
the acute phase of illness. The clinical symptoms of the
confirmed and probable cases were similar, as was the age
distribution of the animals (mean 12.5 ± 5.3 vs. 12.0 ± 6.6
years for confirmed and probable cases, respectively).
Most positive samples (confirmed and probable) were
reported in September (82.9%). The last case was reported on
November 3. The clinical symptoms included mainly fever
(>38.5°C), ataxia, paresis, and paralysis (Table).
Ages of confirmed and probable cases ranged from 3 to 30
years (mean 12 years, median 10 years). There were 4
stallions, 20 mares, and 49 geldings (no information for 3
horses). Most fatal cases (57.1%) were recorded before
September 15 (Figure 2); among fatal cases, 18 (86%) were
euthanized, including one donkey that had neurologic signs
Figure 1. Geographic location of horses with laboratory-confirmed
West Nile virus infection, France.*
*Open circle indicates location of confirmed cases.
Table. Clinical features of disease in 76 horses with confirmed or
probable West Nile virus infection
Clinical signs No. of horses (%)
Fever (>38.5°C) 47 (62%)
Ataxia 55 (72%)
Paresis/paralysis 36 (47%)
Tremor 7   (9%)
Hyperesthesia 6   (8%)
Grinding teeth 3   (4%)
Abnormal behavior 2   (3%)
Hepatitis 1
Figure 2. West Nile confirmed, probable, and fatal equine cases, by
week of clinical onset, France.694 Emerging Infectious Diseases Vol. 7, No. 4, July–August 2001
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followed by a short period of remission and then severe
hepatic failure. Ages were not known for 4 of the 21 fatal
cases. Of the 17 horses for which information was available,
41.2% and 29.6% were in the 6- to 10- and 16- to 20-year age
categories, respectively (Figure 3).
All but three confirmed and probable cases were located
in an area within a radius of 15 km, in a region in Hérault and
Gard provinces called “la petite Camargue.” Thirty-one
(40.8%) of the horses were located within a 5-km radius of the
first two reported cases (Lansargues). Three cases, all fatal,
were located near this area, in Bouches du Rhone Province
approximately 30 km from the first reported cases and 15 km
outside the area where confirmed cases were reported. These
animals, according to the owners, had not moved from this
area during the 3 weeks preceding the onset of symptoms.
However, because of the economic consequences of the
restricted movement measures imposed by the Commission of
European Communities, we assume some owners may not
have observed the restrictions.
We also received 33 samples from other animals, some of
them with neurologic signs, in the infected area during the
outbreak: 16 cows, 8 goats, and 9 others (e.g., camel, dog,
zebra). WN ELISA results were negative for all of them.
No human suspected of having WN infection has been
laboratory-confirmed among 51 persons tested, including 33
hospitalized with signs of encephalitis or meningoencephali-
tis and 18 others with fever or living in close contact with
horses. All these samples were obtained from persons living or
traveling in the infected area during the outbreak. In
contrast, WN IgG antibodies were detected in 3 of 33
gamekeepers working in this area. Two had WN neutralizing
antibodies: one had no WN IgM antibodies; the other (who had
no history of travel during recent years) had low but
detectable IgM antibodies.
Virus Isolation and Molecular
Characterization of Virus Isolates
WN virus was isolated after one passage into C6/36 and
Vero E6 cells from the rachidian bulb of the first confirmed
case and from cerebellum, cortex, and lumbar spinal cord of
another horse that died on September 6. Viral RNA was
extracted from culture supernatants and a reverse
transcription-polymerase chain reaction (RT-PCR) was
performed with primers located in the envelope gene
fragments WN240 and WN132, as described (24). Nucleic acid
sequences were obtained on an automated Applied
Biosystems sequencer (PPE Biosystems, Foster City, CA).
WN virus sequences were aligned by using the multiple
sequence alignment software CLUSTAL.
Phylogenetic analysis of an informative region of the E
glycoprotein gene (Figure 4), using tree-view, showed that the
WN France-2000 isolate belonged to lineage 1 and was closely
related to both horse Morocco-1996 and Italy-1998 isolates. It
is also closely related to mosquito isolates from Senegal-1993,
Kenya-1998, and Romania 1996, as well as to the recent
human isolate from Volgograd-1999. It is distinguishable
from the group including both the New York-1999 and Israel-
1998 isolates, as well as a WN virus recently isolated in our
laboratory from the brain of a human fatal case that occurred
during an outbreak in the governorates of Mahdia and Sfax on
the Tunisian coast in 1997 (H. Triki, unpub. data).
General Survey in Horses
To determine the number of infected horses and thus the
number of asymptomatic infections, a serosurvey study has
been undertaken, which includes all horses located within a
10-km radius of confirmed cases. A total of 5,133 sera were
collected from September to November 2000 from the three
provinces where cases were reported (Herault, Gard, and
Bouches du Rhone). Preliminary results showed 428 (8.3%)
horses with IgG antibodies; 248 had IgM antibodies. Analysis
of these data is in progress, especially to determine rates of
seropositivity for each commune. (A commune is the smallest
French administrative subdivision, which approximately
corresponds to an English parish).
The geographic locations of the seropositive horses were
compared with those of the clinically confirmed and probable
cases (Figure 5).
Figure 3. Age of horses with confirmed, probable, and fatal West Nile
virus infection, France.*
*ND = not determined.
Figure 4. Phylogentic trees based on nucleic sequence data of
E-glycoprotein gene fragments of 254 bp.*
*GenBank accession numbers for the sequences included in the tree are
indicated.695 Vol. 7, No. 4, July–August 2001 Emerging Infectious Diseases
West Nile Virus
Discussion
In this report we described the 2000 WN outbreak in
horses in southern France. Only a few reports of WN virus
encephalomyelitis cases in equines have been published. In
Egypt, a high prevalence of WN antibodies (54%) was
observed during a serologic survey conducted from January to
May 1959 in 436 equines (horses, donkeys, and mules). One
suspected case was fatal and confirmed by viral isolation from
the brain (25). In France during the 1962 WN outbreak in
Camargue, several horses were suspected to be infected (6). In
Morocco (provinces of Kenitra and Larache), 94 equines were
affected from August to mid-October 1996; 42 died. The
disease was reported in all age categories (9), and virus was
isolated from a brain biopsy sample (10). In Italy, from
August to beginning October 1998, 14 horses in Tuscany had
laboratory-confirmed WN virus infection, and 6 animals died
(12). Virus was isolated from a brain biopsy sample (V.
Deubel, unpub. data). In Israel in 1998, 18 serum samples
from horses with encephalomyelitis had WN-neutralizing
antibodies, and virus was isolated from the brain of a stork
(26). In 1999, thousands of geese were destroyed when WN
virus was identified in commercial flocks (27). In the
northeastern United States, 20 horses were infected by WN
virus in 1999; 9 died (28). In 2000, 63 equine cases,
approximately 35% fatal, were confirmed. The first case was
identified in mid-August 2000 (29).
In France, the outbreak started in August 2000 and
ended in November. Most positive samples (80%) were
obtained before September 30. The death rate during this
outbreak (28%) was lower than observed in Morocco (45%),
Italy (43%), and North America (45% and 35%). Most fatal
cases (57.1%) occurred at the beginning of the outbreak,
before September 15. At that time, most veterinary
practitioners thought that the disease could not be cured and
did not apply symptomatic treatment.
Horses, as well as humans, are generally considered to be
dead-end hosts of WN infection; however, little is known
about the duration and magnitude of viremia. Experimental
infections in horses and donkeys in Egypt (25) and in France
(30,31) showed undetectable or low viremia of short duration.
However, these experiments were conducted in different
conditions with different WN strains; therefore, it is difficult
to extrapolate from these results.
During the present outbreak, we were unable to detect
WN virus (by RT-PCR and inoculation into cell culture) in the
blood of a few animals tested, including animals with virus
identified in the brain. In contrast, using intracerebral inocu-
lation into mice, virus was isolated from blood samples during
previous epidemics in Egypt, Israel, South Africa, and France.
During the French outbreak, WN IgM antibodies were
not detected in 18 IgG-positive animals with neurologic signs
from which blood samples were obtained. In the absence of a
second blood sample and in the context of the outbreak, we
concluded that these animals had a recent WN virus infection.
This conclusion was supported by previous serosurveys
conducted in 1999 and 2000 that demonstrated absence of
Flavivirus antibodies in horses (unpub. data). These data
suggest that in some cases IgM response was very low or
nondetectable by commonly used techniques. This may have
implications for the diagnosis of recent infections.
The outbreak appeared limited to a restricted area within
a 15-km radius. This region, near Camargue National Park,
where the 1962 outbreak occurred, is characterized by its
original flora (wetlands, rice fields, garriguea [a geographical
dry area, typical of the mediterranean basin]) and fauna
(more than 300 migratory and resident bird species and large
populations of mosquitoes). No abnormal deaths of birds were
reported. An epidemiologic investigation of WN virus in birds,
including five common nesting species, is in progress. The
vector(s) involved in the present outbreak is (are) still unknown.
Thousands of horses live in this region. Thus, our large
serosurvey should allow us to precisely determine the
geographic distribution of the infection and the number of
asymptomatic infections in the geographic area where the
outbreak occurred.
Two gamekeepers had WN-neutralizing antibodies, and
one of them also had IgM antibodies. Thus, human transmission
occurred during this outbreak. However, in the absence of a
serologic survey, evaluating the level of human infection
among persons living in the infected area is not possible.
The main concern for 2001 is the possibility of persistence
of virus transmission and thus the risk of human infections.
Natural vertical transmission of WN virus in Culex
mosquitoes (32) or survival in overwintering mosquitoes
(3,33) could explain the persistence of the virus. However,
human transmission likely depends on several factors,
including environmental factors, vectors, and amplifying host
conditions. Usually in most countries where WN outbreaks
have been documented, a few cases are reported during
subsequent years (34).
Several questions about WN virus infection are still
unresolved, among them whether WN infection is a major
Figure 5. Geographic location of confirmed and probable clinical
cases and serologically positive cases (according to serosurvey) of
West Nile infection in equines, France. Data are grouped by
commune, the boundaries of which are indicated. (The commune is
the smallest French administrative subdivision, which approxi-
mately corresponds to an English parish). Numbers indicate clinical
cases. Of the 76 cases, 73 are shown; the rest occurred more than 10
km outside the area. Names of communes in which more than one
clinical case occurred are indicated. For each commune, the color (see
key) indicates the number of positive serologic cases. The first cases
were reported in Lansargues.696 Emerging Infectious Diseases Vol. 7, No. 4, July–August 2001
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health problem for humans and horses. The main problem
during this outbreak was not the disease itself but the
economic consequences from the restricted movement
measures imposed by the Commission of the European
Communities (cancellation of horse exhibitions, layoffs of
employees in equestrian centers). Gaining more knowledge
about the role of horses in virus transmission under natural
conditions is important.
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